Biocca et al., 1990 - Google Patents
Expression and targeting of intracellular antibodies in mammalian cells.Biocca et al., 1990
View PDF- Document ID
- 14036811672674555345
- Author
- Biocca S
- Neuberger M
- Cattaneo A
- Publication year
- Publication venue
- The EMBO journal
External Links
Snippet
Genes encoding the heavy and light chains of a hapten‐specific IgM antibody were modified by site‐directed mutagenesis to destroy the hydrophobic leader sequences and allow expression in the cytoplasm of non‐lymphoid cells. The in situ assembly of the mutant heavy …
- 102000004965 antibodies 0 title abstract description 87
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Biocca et al. | Expression and targeting of intracellular antibodies in mammalian cells. | |
| JP2714786B2 (en) | Methods for producing chimeric antibodies | |
| Morrison | Transfectomas provide novel chimeric antibodies | |
| KR100197956B1 (en) | Humanized antibodies | |
| Panté et al. | Interactions and three-dimensional localization of a group of nuclear pore complex proteins. | |
| Nishimura et al. | Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen | |
| CA2090126C (en) | Methods for the production of proteins with a desired function | |
| RU2047177C1 (en) | Method for detection of ige-producing b-lymphocytes | |
| DE69800716T2 (en) | NEW METHOD FOR PRODUCING ANTI-HUMAN ANTIGENT RECEPTORS AND THEIR USE | |
| DE69233104T2 (en) | Antibody production | |
| EP0438310A1 (en) | Method for producing recombinant immunoglobuline | |
| Werge et al. | Intracellular immunization: cloning and intracellular expression of a monoclonal antibody to the p21ras protein | |
| EP0438312A2 (en) | Recombinant human anti-CD18 antibodies | |
| EP0440351A2 (en) | Recombinant human anti-CD18 antibodies | |
| Shepherd | Monoclonal antibodies | |
| US7011974B2 (en) | Method for producing monoclonal antibodies | |
| US20040067496A1 (en) | System for production and screening of monoclonal antibodies | |
| Williams | Novel antibody reagents: production and potential | |
| Greenman et al. | The use of intracellular single-chain antibody fragments to inhibit specifically the expression of cell surface molecules | |
| CHU et al. | Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines | |
| US7338797B2 (en) | Compositions for isolating a cDNA encoding a membrane-bound protein | |
| Spooner et al. | Genetically engineered antibodies for diagnostic pathology | |
| GEE et al. | Dissection of renal brush-border membranes with monoclonal antibodies | |
| US20020197655A1 (en) | Antigen and monoclonal antibody which recognizes the antigen | |
| Suzuki et al. | Preparation and application of anti-idiotypic antibody against anti-gibberellin A4 antibody |